Brooks Laboratories Ltd.

118.20 0.00

29 February 2024, 04:01:00 PM
Volume: 2,307

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.brookslabs.net
Market Cap 310.63 Cr.
Enterprise Value(EV) 313.22 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -5.44 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.63 Trailing Twelve Months Ending 2023-12
Book Value / Share 30.36 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.90 Calculated using Price: 118.35
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.62 Cr. 26,246,738 Shares
FaceValue 10
About Brooks Laboratories Ltd.
The Company was originally incorporated as Brooks Laboratories Limited on January 23, 2002. Company was initially promoted for manufacturing of latest molecules in Injectables, tablets and dry syrups for the domestic customers. The Company set up a facility for manufacturing Tablets, Dry Syrup and Injectables, which was supported by a research and development centre at Baddi, Himachal Pradesh. The Company started its commercial production in the month of June 2006 and became profitable from the very first year of its production.

Brooks Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Brooks Laboratories Ltd. Performance

1 Day
1 Week
-7.98%
1 Month
-21.12%
3 Month
-7.66%
6 Month
+26.82%
1 Year
+24.83%
2 Year
+32.38%
5 Year
+146.76%
10 Year
+731.81%

Brooks Laboratories Ltd. Fundamental Ratios

3 years 2021-03 2022-03 2023-03
Return on Equity (%) -24.48 -23.18 -38.47
Return on Capital Employed (%) -5.33 -18.72 -37.84
Return on Assets (%) -11.95 -10.83 -20.42

Brooks Laboratories Ltd. Balance Sheet

Particulars 4 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 79 87 74 79
Non Curr. Liab. 19 11 3 3
Curr. Liab. 64 49 33 24
Minority Int. 47
Equity & Liab. 162 195 110 106
Non Curr. Assets 112 133 82 76
Curr. Assets 47 61 28 30
Misc. Exp. not W/O
Total Assets 162 195 110 106

Brooks Laboratories Ltd. Profit and Loss

Particulars 4 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 77 91 63 74
Other Income 1 1 0 0
Total Income 78 92 63 75
Total Expenditure -77 -105 -90 -72
PBIDT 1 -13 -26 3
Interest -3 -3 -2 -1
Depreciation -7 -7 -7 -2
Taxation -10 5 7 0
Exceptional Items 0
PAT -19 -19 -31 1
Minority Interest 8 10
Share Associate -15
Other Related Items
Consolidated Net Profit -19 -11 -21 -14
Adjusted EPS -8 -5 -8 -6

Brooks Laboratories Ltd. Cash Flow

Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 -37 -14
Cash Fr. Inv. -5 -25 0
Cash Fr. Finan. 1 64 11
Net Change 0 2 -3
Cash & Cash Eqvt 1 3 0

Brooks Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 66.41 66.41 66.41 66.41 66.41 66.41 66.41 63.59 63.59
Public 33.59 33.59 33.59 33.59 33.59 33.59 33.59 36.41 36.41
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Brooks Laboratories Ltd. Announcements

Thu, 01 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication
Wed, 31 Jan 2024
Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine MonthsEnded December 31 2023.
Approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2023.
Wed, 31 Jan 2024
Board Meeting Outcome for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine MonthsEnded December 31 2023.
Approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine monthsended December 31 2023.

Brooks Laboratories Ltd. Technical Scans

Thu, 29 Feb 2024
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days

Brooks Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 378,183.18 1,577.95 +0.3%
Cipla Ltd. 119,792.84 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. 107,100.71 6,424.25 -0.1%
Zydus Lifesciences Ltd. 95,405.30 941.90 +1.0%
Divi's Laboratories Ltd. 92,624.64 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. 90,256.63 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. 87,793.47 6,105.90 -3.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 32.31 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.49 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 66.98 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.41 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 111.23 6,105.90 -3.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.06 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 4.63 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.11 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.62 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.00 6,105.90 -3.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%

Brooks Laboratories Ltd. FAQ's

What is Brooks Laboratories share price?

Can I buy Brooks Laboratories shares now?

What is the Market Cap of Brooks Laboratories?

What are the key metrics to analyse Brooks Laboratories?

What is the 52 Week High and Low of Brooks Laboratories?

What is the trend of Brooks Laboratories share price?